The agency told Bayer it needs additional time to review the non-hormonal drug, called elinzanetant. Regulators in Canada and the U.K. have already cleared it for use.

A new male birth control pill has passed early safety trials, showing promise with minimal side effects. Larger human trials ...

Sarepta Therapeutics'SRPT brutal week continued Friday after European officials rejected the company's controversial gene therapy, Elevidys.The rejection, which was delivered to European partner ...

A laundry-stealing cat with expensive taste has puzzled and delighted a neighborhood in Auckland, New Zealand, by committing ...